Literature DB >> 33303631

CCR3 deficiency is associated with increased osteoclast activity and reduced cortical bone volume in adult male mice.

Sara Rosendahl1, Rima Sulniute1, Michaela Eklund1, Cecilia Koskinen Holm2, Marcus J O Johansson1, Elin Kindstedt3, Susanne Lindquist1, Pernilla Lundberg4.   

Abstract

Increasing evidence emphasizes the importance of chemokines and chemokine receptors as regulators of bone remodeling. The C-C chemokine receptor 3 (CCR3) is dramatically upregulated during osteoclastogenesis, but the role of CCR3 in osteoclast formation and bone remodeling in adult mice is unknown. Herein, we used bone marrow macrophages derived from adult male CCR3-proficient and CCR3-deficient mice to study the role of CCR3 in osteoclast formation and activity. CCR3 deficiency was associated with formation of giant hypernucleated osteoclasts, enhanced bone resorption when cultured on bone slices, and altered mRNA expression of related chemokine receptors and ligands. In addition, primary mouse calvarial osteoblasts isolated from CCR3-deficient mice showed increased mRNA expression of the osteoclast activator-related gene, receptor activator of nuclear factor kappa-B ligand, and osteoblast differentiation-associated genes. Microcomputed tomography analyses of femurs from CCR3-deficient mice revealed a bone phenotype that entailed less cortical thickness and volume. Consistent with our in vitro studies, the total number of osteoclasts did not differ between the genotypes in vivo. Moreover, an increased endocortical osteoid mineralization rate and higher trabecular and cortical bone formation rate was displayed in CCR3-deficient mice. Collectively, our data show that CCR3 deficiency influences osteoblast and osteoclast differentiation and that it is associated with thinner cortical bone in adult male mice.
Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  bone; chemokine; gene knockout; osteoblast; osteoclast; receptor

Year:  2020        PMID: 33303631      PMCID: PMC7948475          DOI: 10.1074/jbc.RA120.015571

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  28 in total

Review 1.  Chemokines: immunology's high impact factors.

Authors:  C R Mackay
Journal:  Nat Immunol       Date:  2001-02       Impact factor: 25.606

Review 2.  Structural basis of chemokine receptor function--a model for binding affinity and ligand selectivity.

Authors:  Lavanya Rajagopalan; Krishna Rajarathnam
Journal:  Biosci Rep       Date:  2006-10       Impact factor: 3.840

3.  Molecular cloning of human eotaxin, an eosinophil-selective CC chemokine, and identification of a specific eosinophil eotaxin receptor, CC chemokine receptor 3.

Authors:  M Kitaura; T Nakajima; T Imai; S Harada; C Combadiere; H L Tiffany; P M Murphy; O Yoshie
Journal:  J Biol Chem       Date:  1996-03-29       Impact factor: 5.157

4.  CCL2 and CCR2 are Essential for the Formation of Osteoclasts and Foreign Body Giant Cells.

Authors:  Usman A Khan; Saeed M Hashimi; Mahmoud M Bakr; Mark R Forwood; Nigel A Morrison
Journal:  J Cell Biochem       Date:  2016-02       Impact factor: 4.429

5.  Upregulated expression of CCR3 in rheumatoid arthritis and CCR3-dependent activation of fibroblast-like synoviocytes.

Authors:  Xin Liu; Huiyun Zhang; Xin Chang; Jirong Shen; Wenjiao Zheng; Yanan Xu; Junling Wang; Wei Gao; Shaoheng He
Journal:  Cell Biol Toxicol       Date:  2016-08-05       Impact factor: 6.691

6.  Osteopontin--a possible anchor of osteoclasts to bone.

Authors:  F P Reinholt; K Hultenby; A Oldberg; D Heinegård
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

7.  Impaired bone formation and increased osteoclastogenesis in mice lacking chemokine (C-C motif) ligand 5 (Ccl5).

Authors:  Kristofer Wintges; F Timo Beil; Joachim Albers; Anke Jeschke; Michaela Schweizer; Benjamin Claass; Gisa Tiegs; Michael Amling; Thorsten Schinke
Journal:  J Bone Miner Res       Date:  2013-10       Impact factor: 6.741

8.  Estrogen-dependent and C-C chemokine receptor-2-dependent pathways determine osteoclast behavior in osteoporosis.

Authors:  Nikolaus B Binder; Birgit Niederreiter; Oskar Hoffmann; Richard Stange; Thomas Pap; Thomas M Stulnig; Matthias Mack; Reinhold G Erben; Josef S Smolen; Kurt Redlich
Journal:  Nat Med       Date:  2009-03-29       Impact factor: 53.440

9.  Chemokine receptor 3 is a negative regulator of trabecular bone mass in female mice.

Authors:  Subburaman Mohan; Yan Hu; Bouchra Edderkaoui
Journal:  J Cell Biochem       Date:  2019-04-11       Impact factor: 4.480

10.  CCL11, a novel mediator of inflammatory bone resorption.

Authors:  Elin Kindstedt; Cecilia Koskinen Holm; Rima Sulniute; Irene Martinez-Carrasco; Richard Lundmark; Pernilla Lundberg
Journal:  Sci Rep       Date:  2017-07-13       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.